| Product NDC: | 61314-245 |
| Proprietary Name: | Betaxolol Hydrochloride |
| Non Proprietary Name: | Betaxolol Hydrochloride |
| Active Ingredient(s): | 5.6 mg/mL & nbsp; Betaxolol Hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61314-245 |
| Labeler Name: | Falcon Pharmaceuticals, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019270 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20000515 |
| Package NDC: | 61314-245-02 |
| Package Description: | 15 mL in 1 BOTTLE, PLASTIC (61314-245-02) |
| NDC Code | 61314-245-02 |
| Proprietary Name | Betaxolol Hydrochloride |
| Package Description | 15 mL in 1 BOTTLE, PLASTIC (61314-245-02) |
| Product NDC | 61314-245 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Betaxolol Hydrochloride |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20000515 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Falcon Pharmaceuticals, Ltd. |
| Substance Name | BETAXOLOL HYDROCHLORIDE |
| Strength Number | 5.6 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |